Incyte Corporation (INCY) Cash Flow Statement

The Q2 2025 OCF/NI ratio of 0.11 was driven by a $583M working capital outflow, likely reflecting receivable collections or inventory timing, while subsequent quarters normalized above 1.0. The Q2 2026 ratio of 0.87, despite a $281.6M working capital outflow, indicates that net income includes non-cash items or one-time gains that may not recur. Investors should monitor whether the gap between net income and operating cash flow narrows as revenue growth matures.

The FCF trajectory reflects robust revenue growth and disciplined capex, with FCF margins now exceeding 28% for three consecutive quarters. This aligns with the income statement's operating leverage, but the Q2 2026 FCF margin of 29.6% is slightly below Q4 2025's 34.6%, suggesting working capital drag. The sustained high FCF generation supports the company's ability to fund pipeline investments and potential M&A without external financing.

The negligible capex (e.g., $12.4M in Q2 2026) underscores that Incyte's asset-light model generates high incremental cash flows from each revenue dollar. This low capital intensity provides flexibility to allocate cash toward R&D and business development, but it also means that the company's future growth depends on intangible investments rather than physical capacity. The absence of large capex suggests that any future capital needs would likely be for acquisitions or partnerships, not infrastructure.

The large negative working capital changes in Q2 2025 and Q2 2026 likely reflect receivable collections or inventory builds, possibly related to Opzelura launch dynamics or partner milestone timing. These swings are not indicative of deteriorating efficiency, as the company's cash conversion cycle appears stable when viewed over multiple quarters. Investors should adjust for these timing effects to assess the true cash-generating ability of the core business.

The absence of dividends and minimal buybacks indicates that management is retaining cash to fund pipeline development and potential business development opportunities, consistent with the raised guidance and CEO commentary on strategic activity. The $2.0B acquisition outflow in Q2 2024, likely for a business development deal, demonstrates a willingness to deploy capital for growth. Investors should monitor whether this cash pile is used accretively, as the return on invested capital will depend on the success of these investments.

The cumulative OCF/NI ratio of approximately 1.13 suggests that Incyte's earnings quality is solid, with non-cash charges like depreciation and stock-based compensation being more than offset by working capital benefits. This divergence is positive, as it implies that the company is not relying on aggressive accruals to report profits. However, the Q2 2025 and Q2 2026 working capital outflows warrant monitoring, as they could signal a shift if they persist.